+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Automated Cell Counters Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 202 Pages
  • December 2023
  • Region: Global
  • Fairfield Market Research
  • ID: 5916016
The global automated cell counters market is poised for remarkable growth, from USD 6.9 Billion in 2024 to USD 9.9 Billion by 2031. Several key drivers are propelling this growth, transforming the landscape of cell counting in laboratory and clinical settings.

Key Drivers of Market Growth

  • Increasing Prevalence of Chronic and Infectious Diseases: The global rise in chronic and infectious diseases such as cancer, AIDS, sepsis, malaria, influenza, and others is a pivotal factor driving the growth of the automated cell counters market. The necessity for precise cell counting in the diagnosis and treatment of these life-threatening diseases is boosting market demand.
  • Scientific and Technological Advancements: The integration of Big Data technologies and medical image analysis software is revolutionizing cell-based research, driving the demand for automated cell counters. These advancements are enhancing disease identification, reducing patient costs, and improving treatment quality, bolstering market growth.
  • Increased Government and Corporate Funding: Significant investments by governments and corporations in healthcare sectors are facilitating the adoption of advanced technologies. This influx of funding is creating substantial opportunities for the automated cell counters market, benefitting research centers, educational institutes, hospitals, and medical establishments.

Challenges and Limitations

  • High Costs, Scarcity of Skilled Professionals, and Poor Healthcare Infrastructure: The high expenses associated with cell counting procedures, equipment, and apparatus deter investment in medical and research applications. Inadequate healthcare infrastructure in impoverished nations, along with a shortage of trained specialists, poses challenges to market expansion.

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the automated cell counters market. The heightened importance of cell count analysis in COVID-19 patients, particularly in identifying eosinopenia and lymphopenia as potential indicators, led to increased utilization of automated cell counting devices during the pandemic. This trend is expected to persist and continue driving market growth in the post-pandemic era.

Competitive Landscape

The automated cell counters market is moderately competitive, with major players implementing innovative strategies to fulfill product demand and expand their global presence. Companies are focusing on research and development, post-sales and service agreements, partnerships, mergers, and acquisitions to dominate regional markets and cater to evolving customer needs.

Key Companies in the Market

  • Danaher Corporation
  • Biotek Instruments, Inc.
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • ChemoMetec A/S
  • Logos Biosystems
  • Beckman Coulter, Inc.
  • NanoEnTek Inc.
  • Olympus Corporation

Automated Cell Counters Market Segmentation

Automated Cell Counters Market by Product

  • Systems Type
  • Reagents & Consumables

Automated Cell Counters Market by Application

  • Blood Analysis
  • Urine Analysis
  • Microbial Cell Count
  • Cell Line Viability
  • Others

Automated Cell Counters Market by Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa (MEA)


This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Automated Cell Counters Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Automated Cell Counters Market Outlook, 2018 - 2031
3.1. Global Automated Cell Counters Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Systems Type
3.1.1.2. Reagents & Consumables
3.2. Global Automated Cell Counters Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Blood Analysis
3.2.1.2. Urine Analysis
3.2.1.3. Microbial Cell Count
3.2.1.4. Cell Line Viability
3.2.1.5. Others
3.3. Global Automated Cell Counters Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Automated Cell Counters Market Outlook, 2018 - 2031
4.1. North America Automated Cell Counters Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Systems Type
4.1.1.2. Reagents & Consumables
4.2. North America Automated Cell Counters Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Blood Analysis
4.2.1.2. Urine Analysis
4.2.1.3. Microbial Cell Count
4.2.1.4. Cell Line Viability
4.2.1.5. Others
4.2.2. BPS Analysis/Market Attractiveness Analysis
4.3. North America Automated Cell Counters Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Automated Cell Counters Market Outlook, 2018 - 2031
5.1. Europe Automated Cell Counters Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Systems Type
5.1.1.2. Reagents & Consumables
5.2. Europe Automated Cell Counters Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Blood Analysis
5.2.1.2. Urine Analysis
5.2.1.3. Microbial Cell Count
5.2.1.4. Cell Line Viability
5.2.1.5. Others
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Automated Cell Counters Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Automated Cell Counters Market Outlook, 2018 - 2031
6.1. Asia Pacific Automated Cell Counters Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Systems Type
6.1.1.2. Reagents & Consumables
6.2. Asia Pacific Automated Cell Counters Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Blood Analysis
6.2.1.2. Urine Analysis
6.2.1.3. Microbial Cell Count
6.2.1.4. Cell Line Viability
6.2.1.5. Others
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Automated Cell Counters Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Automated Cell Counters Market Outlook, 2018 - 2031
7.1. Latin America Automated Cell Counters Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Systems Type
7.1.1.2. Reagents & Consumables
7.2. Latin America Automated Cell Counters Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
7.2.1.1. Blood Analysis
7.2.1.2. Urine Analysis
7.2.1.3. Microbial Cell Count
7.2.1.4. Cell Line Viability
7.2.1.5. Others
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Automated Cell Counters Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Automated Cell Counters Market Outlook, 2018 - 2031
8.1. Middle East & Africa Automated Cell Counters Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Systems Type
8.1.1.2. Reagents & Consumables
8.2. Middle East & Africa Automated Cell Counters Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Blood Analysis
8.2.1.2. Urine Analysis
8.2.1.3. Microbial Cell Count
8.2.1.4. Cell Line Viability
8.2.1.5. Others
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Automated Cell Counters Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Automated Cell Counters Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Automated Cell Counters Market by Application, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Manufacturer vs by Application Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. Danaher Corporation
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Biotek Instruments, Inc.
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. Alere Inc.
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Bio-Rad Laboratories, Inc.
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. F. Hoffmann-La Roche Ltd
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. ChemoMetec A/S
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. Logos Biosystems
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Beckman Coulter, Inc.
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. NanoEnTek Inc.
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Olympus Corporation
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Danaher Corporation
  • Biotek Instruments, Inc.
  • Alere Inc.
  • Bio-Rad Laboratories, Inc.
  • F. Hoffmann-La Roche Ltd
  • ChemoMetec A/S
  • Logos Biosystems
  • Beckman Coulter, Inc.
  • NanoEnTek Inc.
  • Olympus Corporation

Methodology

Loading
LOADING...